Approvals/TGA/XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack

Approved

STANDARD

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b818b855d2f792ed
Product Name: XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack
Artg Id: 408440
Artg Name: XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2023-08-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/7b87d5503a84eb96f17a8ed8bf7e6498.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5b6e49b8a845921669921f86f0878dd2.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b818b855d2f792ed

Type

Standard